3TC treatment may slow HIV mutations, development of drug resistance.
D004352:Drug Resistance, Microbial; D006678:HIV / Q000187:drug effects / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D019259:Lamivudine; D009154:Mutation; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000627:therapeutic use*
D019259:Lamivudine; D016047:Zalcitabine